Javier Rodriguez Insider Sell Transaction

A few days ago, the CEO – Kidney Care of DaVita HealthCare Partners Inc (NYSE:DVA) 83.70 +0.50 0.60%, Mr. Javier Rodriguez, unloaded a significant amount company shares – 36,466, amounting to $2,972,001 U.S Dollars, based on an average weighted cost of $81.5 per share. It seems he is very active lately as in the last month, he unloaded additional 20,946 shares of the company, worth $1,771,403 USD. This transaction was pretty big one, so clearly it won’t go unnoticed. At the moment, Javier Rodriguez has rights to a total of 100,730 shares or 0.05% of the company’s market cap.

Davita Healthcare Partners Inc Stock Rating, Sentiment and Fundamentals

This move by Javier has led us to believe that the Company is expensive, with chances of the stock price going down. If Davita Healthcare Partners Inc posts $3.77 per share as forecasted by fifteen expert security analysts, Davita Healthcare Partners Inc will have 22.07 forward PE. Their expectations put the year-over-year earnings-per-share growth rate at 12.50%.

* Read How Our Stock Ratings System Works

Despite Javier Rodriguez’s trade, we have no choice but to rate the stock NEUTRAL as our trend following model as illustrated on the chart below, is flashing Buy. Davita Healthcare Partners Inc has seen its stock price increasing by up to 16.56% in the last 200 days, and currently the stock is in a reliable up trend.

Price Chart of Davita Healthcare Partners NYSE:DVA Stock

Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations

The dated 19-05-2015 transaction’s document submitted with the (SEC) is freely accessible here.

Hedge Funds Ownership

According to SEC 13F filings for Q4 2014, 468 investment managers own shares of Davita Healthcare Partners Inc. In the last quarter, Davita Healthcare Partners Inc had 197.62% institutional ownership. That is a very high interest. Its up 140.93% from previous quarter. These institutional investors increased the total shares they own by 248.54 million to 424.89 million this quarter. A total of 30 funds closed their positions in Davita Healthcare Partners Inc and 158 reduced their holdings. There were 50 funds that created new positions and 189 funds that added to their positions.

16 hedge funds are positive about the stock and have it in their Top 10. Some of them are: Foundation Asset Management Lp, Swift Run Capital Management Llc, Summit Partners L P, Timessquare Capital Management Llc, Cognios Capital Llc, Triple Frond Partners Llc, Hikari Power Ltd, Gates Capital Management Inc., Hikari Tsushin Inc., Roundview Capital Llc.

Bluestein R H & Co is the most positive hedge fund on Davita Healthcare Partners Inc, with ownership of 10,650 shares as of Q4 2014 for 0.05% of the fund’s portfolio. Dock Street Asset Management Inc is another positive institutional manager having 57,383 shares of the company or 2.29% of their stocks portfolio. The stock is also 1.06% of the fund’s AUM. First Republic Investment Management Inc. have 0.01% of their stock portfolio invested in the company for 7,274 shares. Further, The Massachusetts-based fund Foster Dykema Cabot & Co Inc Ma disclosed it had acquired a stake worth 2.05% of the fund’s stock portfolio in the company. The Illinois-based fund Geneva Advisors Llc was also a big follower of the stock, possessing 5,435 shares. Davita Healthcare Partners Inc is 0.01% of the fund’s stock portfolio.

DaVita HealthCare Partners NYSE:DVA Company Profile

DaVita HealthCare Partners Inc. offers kidney care and manages and operates medical groups. DaVita HealthCare Partners Inc. operates through DaVita Kidney Care and HealthCare Partners (HCP). The Company’s services include outpatient hemodialysis services, hospital inpatient hemodialysis services, Home-based hemodialysis services, ESRD laboratory services and management services. It operates or provides administrative services through a network of outpatient dialysis centers in the United States that are designed for outpatient hemodialysis. The Company provides hospital inpatient hemodialysis services, excluding physician services, to patients in hospitals throughout the United States. DaVita Kidney Care is a provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. HCP manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, and Florida.

Davita Healthcare Partners Inc was formed in Delaware on 1994-04-04. This company has 57900 employees. As of writing its market cap is: $17.89 billion and it has 216.32 million outstanding shares. Today it has 86.57% shareholders and the institutional ownership is 86.57%. The stock closed at $83.2 yesterday and it had average 2 days volume of 287000 shares. It is up from the 30 days average shares volume of 247747. Davita Healthcare Partners Inc has a 52weeks low of $67.27 and a one year high of $85.17. The stock price is above the 200 days Simple moving average. Davita Healthcare Partners Inc last issued its quarterly earnings report on 05/04/2015. The company reported 0.86 EPS for the quarter, above the consensus estimate of 0.85 by 0.01. The company had a revenue of 3.29 billion for 3/31/2015 and 3.33 billion for 12/31/2014. Therefore, the revenue was -40,052,000 down.

* Shares received upon the satisfaction of performance criteria underlying the awards of performance units.

* The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23 – 2015.

* Represents the weighted average sale price of $81.5006. The range of prices for the sale of these shares was $81.03 – $82.16 – rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff – the Issuer – or a security holder of the Issuer – full information regarding the number of shares purchased or sold at each separate price.

Tagged: DaVita HealthCare Partners - (NYSE:DVA)Javier Rodriguez

...